Clinical trial
Prognostic Value of Angiography-Derived Physiological Indices in Patients Undergoing OCT-Guided Percutaneous Coronary Intervention
NCT07511231 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Angiography-Derived Physiological Indices in Patients Undergoing OCT-Guided Percutaneous Coronary Intervention
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- July 31, 2029
- Enrollment
- 1,800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd))